Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026)

Camp4 Therapeutics (CAMP) posted Other Non Operating Income of -$6.2 million for Q1 2026, up 77.92% sequentially from -$28.0 million in Q4 2025.

Analysis

Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Other Non Operating Income for 3 years, with the latest figure at -$6.2 million in Q1 2026.

  • Quarterly Other Non Operating Income changed N/A year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.0 million (down 124141.38% YoY) and the FY2025 annual result came in at -$29.8 million, changed N/A from the prior year.
  • Other Non Operating Income grew to -$6.2 million in Q1 2026 per CAMP's latest filing, from -$28.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $178000.0 in Q4 2024 and troughed at -$28.0 million in Q4 2025.
  • A 3-year average of -$4.5 million and a median of -$103500.0 in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 91.72% in 2025, down 15847.19% in 2025.
  • Over 3 years, Other Non Operating Income stood at $178000.0 in 2024, then plunged by 15847.19% to -$28.0 million in 2025, then surged by 77.92% to -$6.2 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.2 million, -$28.0 million, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.93 Mn
Mar 31, 2026 -6.19 Mn
Dec 31, 2025 -28.03 Mn
Sep 30, 2025 -1.80 Mn
Jun 30, 2025 -12,000.00
Mar 31, 2025 79,000.00
Dec 31, 2024 178,000.00
Sep 30, 2024 -62,000.00
Jun 30, 2024 -145,000.00
Mar 31, 2024 28,000.00